AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2017
Mar 8, 2017
31565_dirs_2017-03-08_24a323b4-a948-4135-8af7-abc19951aa48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-03-06
Reporting Person: Basil Michelle L (EVP and General Counsel)
More from HAEMONETICS CORP
Annual Report
2026
May 20
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13